Fintech

Mantle's new AI-native prediction market, InsightX, isn't just about forecasts. It's an 'InfoFi' play where capital never sleeps, a key growth signal.

New research reveals AI engines are inventing 1 in 5 celebrity deals and warping financial reputations around single events, signaling a new corporate battleground.

Healthcare Triangle secures $3.6M in complex convertible debt to fuel its AI ambitions. We unpack the high-stakes financing and what it means for the future.

Dapper Labs moves NBA Top Shot Moments to decentralized storage. This isn't just a tech upgrade; it's a strategic move to reclaim trust in a fragile market.

Celebrating 50 years, the largest US ethnic credit union awarded a record $700K to 602 students, reinforcing its deep commitment to the Polish-American community.

The Chinese insurtech's massive share consolidation is a desperate bid to stay on Nasdaq, but it reveals deeper struggles facing Chinese ADRs in the US.

AFX's new Head of Growth, a veteran of HSBC and DBS, signals a bigger trend: DeFi is building a new financial system with Wall Street's old rulebook.

A major shift is underway as crypto-native capital floods into traditional assets, from SpaceX pre-IPO tokens to US equity futures, signaling a new era of financial infrastructure.

Binance re-enters the tokenized stock arena with bStocks, offering 24/7 access to US equities. But what do the regulatory approvals and fine print mean?

As market volatility surges, traders face new risks and opportunities. A deep dive into the strategies and platform tech defining success in today's high-stakes environment.

As Singapore's non-bank lending space heats up, Bizcap unveils a lucrative loyalty program. Is this a game-changer for SME funding or just a costly gambit?

While firms spend billions on tech, a new book argues the biggest data breaches stem from leadership gaps and process failures. Is your boardroom the real front line?

A new financing vehicle aims to de-risk high-integrity carbon projects, but can this "carbon streaming" model unlock Central Asia's climate potential?

A new FDA-designated device aims to filter a deadly protein from the blood of sepsis patients. Can this novel approach finally conquer a global health crisis?

AM Best's 'a-' rating on Ameriprise's new notes isn't just a grade; it's a testament to strategic foresight and a beacon for investors.

FINRA just made remote brokerage inspections permanent. Melissa Adams analyzes the sweeping changes and asks if this push for efficiency maintains investor safety.

Angliabet's reported 15% satisfaction jump from instant withdrawals signals a new era. But does this speed-driven strategy mask deeper risks for UK players?

A new CFD broker hit $300B in its first year by targeting emerging markets. But its rapid growth reveals a strategy built on speed, risk, and regulatory gaps.

Amedea Pharma's Medical Innovation Olympics isn't just a contest; it's a data-driven crucible for new treatments, with longevity medicine taking center stage.

A new platform promises to let an AI trade for you, redefining the side hustle. But as CamdClaw democratizes quant trading, critical questions on risk arise.